1.00 / AMA PRA Category 1 CreditsTM 1.00 / CE for Nurses
Provided by Physicians' Education Resource®, LLC (PER®)
This activity is supported by independent educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals.
Atopic dermatitis is a chronic, relapsing skin disease which places a significant burden on patients, resulting in a lower quality of life. In moderate-to-severe disease, patients also suffer from high levels of psychological distress, increased prevalence of psychiatric diseases, and increased risk of cardiometabolic comorbidities. During this Medical Crossfire®, dermatology experts will engage in a multidisciplinary roundtable moderated by a family physician with the additional perspective of a patient’s treatment journey as video clips throughout the discussion. Topics covered include disease manifestations, diagnostic criteria, pathophysiology of moderate-to-severe atopic dermatitis and treatment approaches with both current and new and emerging therapies. Faculty will emphasize the importance of individualized treatment plans in a patient-centered approach.
This activity is directed to dermatologists, allergists, immunologists, rheumatologists, primary care physicians, researchers; other healthcare professionals interested in the treatment of Atopic Dermatitis are invited to participate.
After completing this activity, clinicians should be better able to:
Outline the burden of atopic dermatitis (AD) on patients.
Discuss the most recent information on the epidemiology and pathogenesis of AD, and how this is likely to affect the management of patients with AD.
Analyze how older and newer therapies fit into the AD treatment paradigm.
Clarify how a multidisciplinary, patient-centered, approach to care may improve patient outcomes in AD.
Conflict Of Interest Disclosure Policy
As a sponsor accredited by the ACCME, it is the policy of PER® to ensure fair balance, independence, objectivity, and scientific rigor in all of its CME activities. In compliance with ACCME guidelines, PER® requires everyone who is in a position to control the content of a CME activity to disclose all relevant financial relationships with commercial interests. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months that creates a COI. Additionally, PER® is required by ACCME to resolve all COI. PER® has identified and resolved all COI prior to the start of this activity by using a multistep process.
Paul P. Doghramji, MD, FAAFP Attending Physician, Collegeville Family Practice Medical Director, Health Services, Ursinus College, Collegeville, PA Cofounder, Brookside Family Practice and Pediatrics Assistant Medical Director, Health Services, Hill School, Pottstown, PA
Dr. Doghramji has no relevant financial relationships with commercial interests.
Chair Peter Lio, MD Assistant Clinical Professor Dermatology and Pediatrics Northwestern University, Feinberg School of Medicine Chicago, IL
Christine Go, MMS, PA-C Leone Dermatology Arlington Heights, IL
Ms. Go has no relevant financial relationships with commercial interests.
Pamela P. Fantus, RN, MSN Patient
Ms. Fantus has no relevant financial relationships with commercial interests
Accredited Provider Disclosure
The staff of Physicians' Education Resource®, LLC, have no relevant financial relationships with commercial interests to disclose.
AMA PRA Category 1 Credit(s)TM
Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physicians' Education Resource®, LLC designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 CreditTM . Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CE for Nurses
Physicians' Education Resource®, LLC is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.
Physicians' Education Resource®, LLC is approved by the California Board of Registered Nursing, Provider #16669, for 1.00 Contact Hour.
Disclosure of Unlabeled Use
This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing education purposes only, and is not meant to substitute for the independent medical judgment of a physician or nurse relative to diagnostic, treatment, or management options for a specific patient's medical condition.
The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER® or any of the companies that provided commercial support for this activity.
In order to receive credit, participants must complete the pre-assessment questions, view the activity in its entirety, and complete the post-test and program evaluation. Participants must also score at least 70% on the post-test. You will receive a digital copy of your credit certificate at the conclusion of the activity. Your online certificate will be saved on myCME within your Profile/CME History, which you can access at any time.